Astera Labs (NASDAQ:ALAB) Stock Breaks Below 200-Day Moving Average - Should You Sell?

Key Points

• Astera Labs shares fell below their 200-day moving average, trading as low as $226 and last changing hands at $229.67, versus a 200-day average of $255.22.
• Analyst sentiment remains mixed but leans positive: the stock has a consensus “Moderate Buy” rating and an average price target of $340.79, despite some firms downgrading it to “Hold” or “Market Perform.”
• The company reported strong quarterly results, with revenue up 104.5% year over year and EPS of $0.80 beating estimates; however, insiders sold roughly $127.3 million of stock over the past 90 days.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $255.22 and traded as low as $226.00. Astera Labs shares last traded at $229.67, with a volume of 5,469,500 shares trading hands.

Analysts Set New Price Targets

Several research firms have weighed in on ALAB. Roth Capital reaffirmed a "buy" rating and set a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Zacks Research lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, October 5th. Northland Securities cut shares of Astera Labs from an "outperform" rating to a "market perform" rating in a report on Friday, October 9th. Jefferies Financial Group raised their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada lifted their target price on shares of Astera Labs from $425.00 to $500.00 and gave the company an "outperform" rating in a report on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $340.79.

Astera Labs Price Performance

The company has a market cap of $39.85 billion, a P/E ratio of 113.70 and a beta of 3.68. The company's 50-day moving average is $307.01 and its two-hundred day moving average is $255.22.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business had revenue of $392.40 million for the quarter, compared to analysts' expectations of $360.85 million. During the same period in the prior year, the firm posted $0.44 EPS. The firm's quarterly revenue was up 104.5% on a year-over-year basis. Equities research analysts anticipate that Astera Labs, Inc. will post 2.71 EPS for the current year.

Insider Transactions at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the transaction, the director owned 253,863 shares in the company, valued at $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 8,994 shares of the company's stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $2,472,990.24. Following the transaction, the director directly owned 3,309 shares in the company, valued at approximately $909,842.64. The trade was a 73.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 408,558 shares of company stock valued at $127,306,034. Insiders own 10.40% of the company's stock.

Hedge Funds Weigh In On Astera Labs

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs in the 2nd quarter worth approximately $25,000. Archer Investment Corp purchased a new position in shares of Astera Labs in the second quarter worth approximately $30,000. Transamerica Financial Advisors LLC bought a new stake in Astera Labs during the second quarter valued at approximately $35,000. Continuum Advisory LLC bought a new stake in Astera Labs during the second quarter valued at approximately $37,000. Finally, GK Wealth Management LLC bought a new stake in Astera Labs during the third quarter valued at approximately $29,000. Institutional investors own 60.47% of the company's stock.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.